Evidence explorer

Every claim we hold, and how far we can stand behind it.

142 claims across 39 products. 30% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.

What this corpus is made of

Evidence class	Claims	Confirmed	What it can support
Peer-reviewed study	19	5	Independent review before publication. The only class that survives a sceptical committee unaided.
Regulatory filing	4	0	A statement made to a regulator, where being wrong has consequences.
Independent report	32	9	Analysis by someone with no stake in the sale.
Customer case	4	3	A real deployment, but selected and framed by someone with an interest.
Press release	63	23	The vendor's own announcement. Useful for dates and facts, not for outcomes.
Vendor page	20	2	Marketing copy. Establishes what is claimed, never that it is true.

Showing 5 of 5 matching claims (142 in the full corpus) · 40% of this selection is confirmed · clear filters

Received FDA 510(k) clearance and launched the next-generation HeartFlow Plaque Analysis platform in September 2025
HeartFlow Analysis (FFRct)Press releaseConfirmed2025-09-22Open source ↗
Provenance
Claim ID
clm_29c575ae0472e53b405e
Version
1
Workflow
Imaging & Diagnostic AI
Dimension
evidence strength
Retrieved
2026-08-27
Reviewer
healthit-gate-v1
Source URL
https://ir.heartflow.com/news-releases/news-release-details/heartflow-announces-fda-510k-clearance-and-launch-next
Completed an upsized IPO on Nasdaq (HTFL) raising ~$364.2M in gross proceeds at $19/share; shares began trading Aug 8, 2025
HeartFlow Analysis (FFRct)Press releaseConfirmed2025-08-11Open source ↗
Provenance
Claim ID
clm_6d2284fb4d9b5d1ed5da
Version
1
Workflow
Imaging & Diagnostic AI
Dimension
market durability
Retrieved
2026-08-27
Reviewer
healthit-gate-v1
Source URL
https://ir.heartflow.com/news-releases/news-release-details/heartflow-inc-announces-closing-upsized-initial-public-offering
CEO Prashant Warier states Qure.ai aims to reach profitability in the next financial year and pursue an IPO within roughly two years (May 2025)
qXR (Chest X-ray AI Suite)Press releaseUnverified2025-05-20Open source ↗
Provenance
Claim ID
clm_feb6e7535e4e9cab9d13
Version
1
Workflow
Imaging & Diagnostic AI
Dimension
market durability
Retrieved
2026-08-27
Reviewer
healthit-gate-v1
Source URL
https://m.economictimes.com/tech/artificial-intelligence/healthcare-ai-startup-qure-ai-aiming-for-ipo-in-two-years-ceo-says/articleshow/121286035.cms
Completed a $65M Series D led by Lightspeed and 360 ONE Asset (Sept 2024); solutions deployed in 90+ countries across 3,000+ sites
qXR (Chest X-ray AI Suite)Press releaseUnverified2024-09-25Open source ↗
Provenance
Claim ID
clm_9db738bc406a8512a625
Version
1
Workflow
Imaging & Diagnostic AI
Dimension
market durability
Retrieved
2026-08-27
Reviewer
healthit-gate-v1
Source URL
https://www.globenewswire.com/news-release/2024/09/25/2953204/0/en/Global-healthcare-AI-innovator-Qure-ai-completes-65-million-Series-D-funding-round-led-by-Lightspeed-and-360One-Asset.html
Completed SOC 2 Type II and HIPAA audits for the Viz.ai One Platform, marking the fourth consecutive year of SOC 2 Type II compliance
Viz.ai One PlatformPress releaseUnverified2024-02-26Open source ↗
Provenance
Claim ID
clm_475a430afcb48493c9c8
Version
1
Workflow
Imaging & Diagnostic AI
Dimension
trust governance
Retrieved
2026-08-27
Reviewer
healthit-gate-v1
Source URL
https://www.viz.ai/news/viz-ai-announces-successful-completion-of-soc-2-type-ii-hipaa-audits-for-viz-ai-one-platform

Know a source we are missing?